Single Shot Intrasplenic Immunization: An Advantageous Procedure for Production of Monoclonal Antibodies Specific for Human Fibrin Fragments
- 1 January 1984
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 3 (4) , 381-385
- https://doi.org/10.1089/hyb.1984.3.381
Abstract
We describe the use of the single shot intrasplenic immunization technique as a particularly effective procedure for the production of specific monoclonal antibodies against a high molecular weight antigen. We found that with this technique several different, completely specific monoclonal antibodies could be produced against high molecular weight crosslinked fibrin degradation products. These results contrasted with those obtained using conventional multidose immunization, which only produced monoclonal antibodies that were cross-reactive with fibrinogen and/or noncrosslinked fibrin degradation products.This publication has 7 references indexed in Scilit:
- Intrasplenic primary immunization for the production of monoclonal antibodiesJournal of Immunological Methods, 1984
- An immunoassay for human D dimer using monoclonal antibodiesThrombosis Research, 1983
- Giant fibrin fragments derived from crosslinked fibrin: Structure and clinical implicationThrombosis Research, 1980
- Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implicationsJournal of Clinical Pathology, 1980
- Monoclonal antibodies against human lymphocyte antigensNature, 1978
- Antibodies to major histocompatibility antigens produced by hybrid cell linesNature, 1977
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975